Suchergebnisse - "Prostatic Neoplasms/blood"

Circulating innate lymphoid cells are dysregulated in patients with prostate cancer

Autoren: Maresca D. C. La Civita E. Romano B. et al.

Quelle: Cell Mol Biol Lett
Cellular & Molecular Biology Letters, Vol 30, Iss 1, Pp 1-23 (2025)
Cellular & molecular biology letters, vol. 30, no. 1, pp. 48

Schlagwörter: Prostatic Neoplasms / pathology, Lymphocytes / metabolism, Male, Innate lymphoid cells, Prostatic Neoplasms / immunology, 616.07, ILC2s, IL-13, IL-18, IL-33, ILC1s, Prostate cancer, Cell Line, Tumor, Humans, Prostatic Neoplasms/immunology, Prostatic Neoplasms/pathology, Prostatic Neoplasms/blood, Immunity, Innate, Lymphocytes/immunology, Lymphocytes/metabolism, Lymphocytes/pathology, Middle Aged, Cytokines/metabolism, Cytokines/blood, Aged, Leukocytes, Mononuclear/immunology, Lymphocytes, QH573-671, Prostatic Neoplasms / blood, Leukocytes, Mononuclear / immunology, Prostatic Neoplasms, Cytokines / blood, Cytokines / metabolism, Leukocytes, Mononuclear, Lymphocytes / pathology, Cytokines, Lymphocytes / immunology, Cytology, Research Article

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40247153
https://doaj.org/article/71b194f34d0b4f3d819b24c3a1ddabcd
https://hdl.handle.net/11588/1006455
https://archive-ouverte.unige.ch/unige:186016
https://doi.org/10.1186/s11658-025-00725-7
https://serval.unil.ch/resource/serval:BIB_C66FE4F0E846.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C66FE4F0E8468
https://serval.unil.ch/notice/serval:BIB_C66FE4F0E846

Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer

Autoren: Eva Welsch Lilli Bonstingl Barbara Holzer et al.

Quelle: Clin Exp Metastasis

Schlagwörter: Male, Glutamate Carboxypeptidase II, Aged, 80 and over, Neoplastic Cells, Circulating/pathology [MeSH], Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Parsortix, Prostate-Specific Antigen/blood [MeSH], Humans [MeSH], Liquid biopsy, Neoplasm Metastasis [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Antigens, Surface [MeSH], Glutamate Carboxypeptidase II/blood [MeSH], Research Paper, In Situ Hybridization [MeSH], Male [MeSH], Biomarkers, Tumor/blood [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], qPCR, Gene expression, Circulating tumor cells, Prostate cancer, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Neoplastic Cells, Circulating, Prognosis, Antigens, Surface, Biomarkers, Tumor, Humans, Neoplasm Metastasis, In Situ Hybridization, Aged, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39305397
https://repository.publisso.de/resource/frl:6518781

Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT study

Autoren: Kilian, Kilian Lotz, Vincent Einspieler, Holger et al.

Quelle: Clin Epigenetics
Clinical Epigenetics, Vol 17, Iss 1, Pp 1-11 (2025)

Schlagwörter: Male, Positron Emission Tomography Computed Tomography Methods, PET/CT, Castration-Resistant Blood, Biomarkers, Tumor Blood, DNA Methylation Genetics, Gallium Radioisotopes, QH426-470, Castration-Resistant Genetics, Circulating Tumor DNA, Biomarkers, Tumor Genetics, Edetic Acidanalogs & Derivatives, Positron Emission Tomography Computed Tomography, Castration-Resistant Diagnostic Imaging, PSMA, Genetics, Biomarkers, Tumor, Humans, Prostatic Neoplasms Genetics, cfDNA, Circulating Tumor DNA Genetics, Prostatic Neoplasms Blood, Gallium Isotopes, Aged, Aged, 80 and over, Cancer och onkologi, DNA methylation, Prostate cancer, Circulating Tumor DNA Blood, Research, Prostatic Neoplasms Diagnostic Imaging, Prostate-Specific Antigen Genetics, Prostatic Neoplasms, Prostate-Specific Antigen Blood, Middle Aged, DNA Methylation, Prostate-Specific Antigen, Prognosis, Cross-Sectional Studies, Cancer and Oncology, Medicine, Epigenetics

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40001235
https://doaj.org/article/9b26a5d110dc4345be0fe63f48111ea1
https://phaidra.vetmeduni.ac.at/o:4004
https://doi.org/10.1186/s13148-025-01811-5
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-236695

Impact of persistent PSA after salvage radical prostatectomy: a multicenter study

Autoren: Felix Preisser Reha-Baris Incesu Pawel Rajwa et al.

Quelle: Prostate Cancer Prostatic Dis

Schlagwörter: Male, ANTIGEN, Article, 3211 Oncology and carcinogenesis, Biomarkers, Tumor, Humans, 1112 Oncology and Carcinogenesis, FUNCTIONAL OUTCOMES, Aged, Retrospective Studies, Prostatectomy, Salvage Therapy, Science & Technology, 3202 Clinical sciences, Prostatic Neoplasms, ADENOCARCINOMA, MEN, Urology & Nephrology, Prostate-Specific Antigen, Middle Aged, Prognosis, CANCER, 3. Good health, Oncology, PREDICTIVE FACTORS, SURVIVAL, Neoplasm Recurrence, Local, Follow-Up Studies [MeSH], Neoplasm Recurrence, Local/blood [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Salvage Therapy [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Neoplasm Recurrence, Local/surgery [MeSH], Male [MeSH], 692/699/67/589/466, Biomarkers, Tumor/blood [MeSH], Prognosis [MeSH], 692/699/2768/1753/466, Prostatic Neoplasms/surgery [MeSH], Prostatectomy/methods [MeSH], article, Life Sciences & Biomedicine, DETECTABLE PSA, Follow-Up Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37803241
https://repository.publisso.de/resource/frl:6519717

Correlation of Cytokine Profiles with Prostate-Specific Antigen and Disease Grade in Prostate Cancer

Autoren: Sulić, Jelena Marijanović, Inga Kraljević, Marija et al.

Quelle: Med Sci Monit Basic Res

Schlagwörter: Male, Bosnia and Herzegovina, Interleukin-10 / blood, Prostatic Neoplasms / blood, Tumor Necrosis Factor-alpha, Biomarkers, Tumor / blood, Prostatic Neoplasms, Adenocarcinoma / blood, Cytokines / blood, Prostate-Specific Antigen, Middle Aged, Adenocarcinoma, Interleukin-10, Tumor Necrosis Factor-alpha / blood, Human Study, Cross-Sectional Studies, Biomarkers, Tumor, Humans, Cytokines, Neoplasm Grading, Chemokine CCL2, Chemokine CCL2 / blood, Prostate-Specific Antigen / blood, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39568188

Associations between genetically predicted concentrations of plasma proteins and the risk of prostate cancer

Autoren: Sun, Wenguo Li, Haoming Shi, Wenjie et al.

Quelle: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)

Schlagwörter: Male, Proteomics, 0301 basic medicine, 0303 health sciences, Prostate cancer, Drug targets, Research, Plasma proteins, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Membrane Proteins, Prostatic Secretory Proteins, Blood Proteins, Mendelian Randomization Analysis, Genetic Predisposition to Disease [MeSH], Proteomics/methods [MeSH], Mendelian randomization, Polymorphism, Single Nucleotide [MeSH], Humans [MeSH], Prostatic Neoplasms/epidemiology [MeSH], Blood Proteins/genetics [MeSH], Prostatic Neoplasms/blood [MeSH], Risk Factors [MeSH], Blood Proteins/analysis [MeSH], Prostatic Neoplasms/genetics [MeSH], Prostatic Secretory Proteins/genetics [MeSH], Male [MeSH], Autophagy-Related Protein 7/blood [MeSH], Biomarkers, Tumor/blood [MeSH], Biomarkers, Tumor/genetics [MeSH], Prostatic Secretory Proteins/blood [MeSH], Autophagy-Related Protein 7/genetics [MeSH], Mendelian Randomization Analysis [MeSH], Autophagy-Related Protein 7, Polymorphism, Single Nucleotide, 3. Good health, 03 medical and health sciences, Risk Factors, Biomarkers, Tumor, Humans, Genetic Predisposition to Disease, RC254-282

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39068416
https://doaj.org/article/1e4db5a270224922aa3704381ca1192f
https://repository.publisso.de/resource/frl:6507606

Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center

Autoren: Matthias Jahnen Tanja Hausler Valentin H. Meissner et al.

Quelle: World J Urol

Schlagwörter: Male, Aged, 80 and over, Adult, Image-Guided Biopsy, Prostatic Neoplasms, Middle Aged, Risk Assessment, ddc, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Original Article, Prostate cancer, mpMRI, Prostate biopsy, Risk models, Humans, Aged, 80 and over [MeSH], Aged [MeSH], Risk Assessment [MeSH], Adult [MeSH], Humans [MeSH], Image-Guided Biopsy [MeSH], Predictive Value of Tests [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Hospitals, High-Volume [MeSH], Male [MeSH], Prostatic Neoplasms/diagnosis [MeSH], Multiparametric Magnetic Resonance Imaging [MeSH], Multiparametric Magnetic Resonance Imaging, Hospitals, High-Volume, Aged, Retrospective Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38702557
https://repository.publisso.de/resource/frl:6507158
https://mediatum.ub.tum.de/doc/1770842/document.pdf

Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery

Autoren: Gisa Mehring Christina Steinbach Randi Pose et al.

Quelle: World J Urol

Schlagwörter: Male, Glutamate Carboxypeptidase II, Prostatectomy, L-Lactate Dehydrogenase, Prostatic Neoplasms, Middle Aged, Alkaline Phosphatase, Prognosis, Carcinoembryonic Antigen, 03 medical and health sciences, 0302 clinical medicine, Phosphopyruvate Hydratase, Antigens, Surface, Neoplasm Recurrence, Local/blood [MeSH], Antigens, Surface/blood [MeSH], Aged [MeSH], Humans [MeSH], Salvage surgery, Prostatic Neoplasms/blood [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Carcinoembryonic Antigen/blood [MeSH], Alkaline Phosphatase/blood [MeSH], Biomarker, Glutamate Carboxypeptidase II/blood [MeSH], PET, Original Article, L-Lactate Dehydrogenase/blood [MeSH], Male [MeSH], Biomarkers, Tumor/blood [MeSH], Phosphopyruvate Hydratase/blood [MeSH], Neoplasm Recurrence, Local/diagnostic imaging [MeSH], Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatic Neoplasms/surgery [MeSH], Biochemical recurrence, Prostatectomy/methods [MeSH], Biomarkers, Tumor, Humans, Neoplasm Recurrence, Local, Aged, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38656636
https://repository.publisso.de/resource/frl:6520329

Relationship Between Prostate-Specific Antigen, Alkaline Phosphatase Levels, and Time- to-Tumor Shrinkage: Understanding the Progression of Prostate Cancer in a Longitudinal Study

Autoren: Liaqat, Madiha Khan, Rehan Ahmad Fischer, Florian et al.

Quelle: BMC Urol
BMC Urology, Vol 24, Iss 1, Pp 1-8 (2024)

Schlagwörter: Male, Prostate cancer, Time Factors, Research, Prostatic Neoplasms, Biomarker, Disease Progression [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Humans [MeSH], Alkaline phosphatase, Longitudinal Studies [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Prostate-specific antigen, Time Factors [MeSH], Alkaline Phosphatase/blood [MeSH], Male [MeSH], Joint model, Tumor Burden [MeSH], Prostate-Specific Antigen, Middle Aged, Alkaline Phosphatase, Diseases of the genitourinary system. Urology, Tumor Burden, 3. Good health, Disease Progression, Humans, RC870-923, Longitudinal Studies, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38956570
https://doaj.org/article/99674896272a426981057e3425cce8c8
https://repository.publisso.de/resource/frl:6520413

Prostate zones and cancer: lost in transition?: lost in transition?

Autoren: Ali, Amin Du Feu, Alexander Oliveira, Pedro et al.

Quelle: Ali, A, Du Feu, A, Oliveira, P, Choudhury, A, Bristow, R G & Baena, E 2022, 'Prostate zones and cancer : lost in transition?', Nature Reviews. Urology, vol. 19, no. 2, pp. 101-115. https://doi.org/10.1038/s41585-021-00524-7

Schlagwörter: Male, 0301 basic medicine, Prostate/pathology, 0303 health sciences, prostate, Manchester Cancer Research Centre, Prostate-Specific Antigen/blood, Prostate, Prostatic Neoplasms, Prostatic Neoplasms/blood, Organ Size, Prostate-Specific Antigen, prostate cancer, Prognosis, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, 3. Good health, 03 medical and health sciences, Global Development Institute, Biomarkers, Tumor/blood, ResearchInstitutes_Networks_Beacons/global_development_institute, name=Global Development Institute, Biomarkers, Tumor, Tumor/blood, Humans, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34667303
https://www.nature.com/articles/s41585-021-00524-7
https://christie.openrepository.com/handle/10541/624755
https://chesterrep.openrepository.com/handle/10034/626263
https://www.nature.com/articles/s41585-021-00524-7.pdf

PHI density prospectively improves prostate cancer detection

Autoren: Stephan, Carsten Jung, Klaus Lein, Michael et al.

Quelle: World J Urol

Schlagwörter: Male, Prostate cancer, Prostate, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Decision curve analysis (DCA), Tumor Burden, 3. Good health, Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Humans [MeSH], Prospective Studies [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Original Article, Male [MeSH], PHI density (PHID), Prostate/pathology [MeSH], Prostate health index (PHI), Prostatic Neoplasms/diagnosis [MeSH], Tumor Burden [MeSH], 03 medical and health sciences, 0302 clinical medicine, Humans, Prospective Studies, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, Aged

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00345-020-03585-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33471165
https://link.springer.com/article/10.1007/s00345-020-03585-2
https://www.ncbi.nlm.nih.gov/pubmed/33471165
https://link.springer.com/content/pdf/10.1007/s00345-020-03585-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33471165/
https://repository.publisso.de/resource/frl:6451133
https://refubium.fu-berlin.de/handle/fub188/40562
https://doi.org/10.17169/refubium-40282
https://doi.org/10.1007/s00345-020-03585-2

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

Autoren: Peter Albers Andreas Hiester F Mones et al.

Quelle: Eur Radiol

Schlagwörter: Image-Guided Biopsy, Male, Disease Progression [MeSH], Image-Guided Biopsy/methods [MeSH], Neoplasm Grading [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Ultrasonography [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Male [MeSH], Magnetic resonance imaging, Prostate cancer, Assessment, Watchful Waiting [MeSH], Early diagnosis, Humans [MeSH], Predictive Value of Tests [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Urogenital, Imaging-guided biopsy, Prostatic Neoplasms/therapy [MeSH], Magnetic Resonance Imaging/methods [MeSH], risk, Multiparametric Magnetic Resonance Imaging [MeSH], Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Magnetic Resonance Imaging, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Disease Progression, Humans, Multiparametric Magnetic Resonance Imaging, Neoplasm Grading, Watchful Waiting, 10. No inequality, Aged, Retrospective Studies, Ultrasonography

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00330-020-06997-1.pdf
https://pubmed.ncbi.nlm.nih.gov/32591887
https://link.springer.com/article/10.1007/s00330-020-06997-1
https://pubmed.ncbi.nlm.nih.gov/32591887/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553894
https://link.springer.com/content/pdf/10.1007/s00330-020-06997-1.pdf
https://repository.publisso.de/resource/frl:6469258

PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions

Autoren: Stefano Luzzago Giuseppe Rosiello Marina Deuker et al.

Quelle: World J Urol

Schlagwörter: Male, Asian, Prostatic Neoplasms, Censuses, AANHPI, AAPI, Native Hawaiian, NHOPI, Pacific Islander, Prostate cancer survival, Racial disparities, SEER, Aged, Asian Americans, European Continental Ancestry Group, Humans, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Prostate-Specific Antigen, Retrospective Studies, United States, White People, Neoplasm Grading [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], United States [MeSH], Asian Americans/statistics, Prostatic Neoplasms/mortality [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Original Article, Neoplasm Staging [MeSH], Censuses [MeSH], Male [MeSH], Prostatic Neoplasms/classification [MeSH], European Continental Ancestry Group/statistics, Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prognosis [MeSH], 3. Good health, 03 medical and health sciences, 0302 clinical medicine

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00345-020-03242-8.pdf
https://pubmed.ncbi.nlm.nih.gov/32458094
https://link.springer.com/content/pdf/10.1007/s00345-020-03242-8.pdf
https://moh-it.pure.elsevier.com/en/publications/psa-stage-grade-and-prostate-cancer-specific-mortality-in-asian-a
https://link.springer.com/article/10.1007/s00345-020-03242-8
https://pubmed.ncbi.nlm.nih.gov/32458094/
http://europepmc.org/article/MED/32458094
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969699/
https://hdl.handle.net/2434/881545
https://doi.org/10.1007/s00345-020-03242-8
https://repository.publisso.de/resource/frl:6466830

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

Autoren: Katharina Möller Anna Lena Wecker Doris Höflmayer et al.

Quelle: Virchows Arch

Schlagwörter: Male, Oncogene Proteins, Fusion, Heterogeneous Nuclear Ribonucleoprotein A1, Neoplasm Grading [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], hnRNPA1, TMA, Margins of Excision [MeSH], Prostatic Neoplasms/blood [MeSH], Risk Factors [MeSH], Tissue Array Analysis [MeSH], Up-Regulation [MeSH], Prognosis, Lymphatic Metastasis [MeSH], Heterogeneous Nuclear Ribonucleoprotein A1/analysis [MeSH], Original Article, Neoplasm Staging [MeSH], Male [MeSH], Neoplasm Recurrence, Local [MeSH], Biomarkers, Tumor/analysis [MeSH], Kallikreins/blood [MeSH], Prostatic Neoplasms/surgery [MeSH], Gene Fusion [MeSH], Prostate cancer, Cell Proliferation [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Oncogene Proteins, Fusion/genetics [MeSH], Predictive Value of Tests [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/genetics [MeSH], Immunohistochemistry [MeSH], Biomarkers, Tumor/blood [MeSH], Biomarkers, Tumor/genetics [MeSH], Prostatectomy [MeSH], Prostatic Neoplasms/chemistry [MeSH], 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Biomarkers, Tumor, Humans, Aged, Cell Proliferation, Neoplasm Staging, Prostatectomy, 2. Zero hunger, Margins of Excision, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Immunohistochemistry, 3. Good health, Lymphatic Metastasis, Kallikreins, Gene Fusion, Neoplasm Grading, Neoplasm Recurrence, Local

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00428-020-02834-4.pdf
https://pubmed.ncbi.nlm.nih.gov/32417965
https://link.springer.com/article/10.1007/s00428-020-02834-4
https://pubmed.ncbi.nlm.nih.gov/32417965/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581599
https://link.springer.com/content/pdf/10.1007/s00428-020-02834-4.pdf
https://repository.publisso.de/resource/frl:6467326

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Autoren: Dirix, Piet Strijbos, Michiel den Mooter, Tom Van et al.

Weitere Verfasser: Dirix, Piet Strijbos, Michiel den Mooter, Tom Van et al.

Quelle: Future Oncology. 16:1083-1089

Schlagwörter: Adult, Male, Adolescent, Prostate-Specific Antigen/blood, sexual health, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Thiohydantoins/therapeutic use, Neoplasm Recurrence, Local/blood, patient safety, Humans, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Prostatectomy, Salvage Therapy, Prostatic Neoplasms, Prostatic Neoplasms/blood, Androgen Antagonists, Middle Aged, Prostate-Specific Antigen, Combined Modality Therapy, 3. Good health, Salvage Therapy/methods, Kallikreins/blood, Treatment Outcome, Combined Modality Therapy/methods, Prostatectomy/methods, Disease Progression, young adult, Kallikreins, Patient Safety, Neoplasm Recurrence, Local, Sexual Health, aged, 80 and over, Androgen Antagonists/therapeutic use

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/32356465
https://pubmed.ncbi.nlm.nih.gov/32356465/
https://biblio.ugent.be/publication/8674271
https://www.scilit.net/article/a652a11e782d22f6b00395e8741f6cd8
https://www.ncbi.nlm.nih.gov/pubmed/32356465
https://hdl.handle.net/20.500.14017/9e132445-966b-48b3-bb03-16dd5fe39c36
https://doi.org/10.2217/fon-2020-0056
https://biblio.vub.ac.be/vubir/phase-ii-openlabel-study-investigating-apalutamide-in-patients-with-biochemical-progression-after-radical-prostatectomy(9e132445-966b-48b3-bb03-16dd5fe39c36).html

Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients

Autoren: Felix Böckelmann Florian Putz Karoline Kallis et al.

Quelle: Strahlenther Onkol

Schlagwörter: Male, Organs at Risk, Adenocarcinoma, Radiotherapy Setup Errors, Patient Positioning, Motion, 03 medical and health sciences, 0302 clinical medicine, Fiducial Markers, Humans, ddc:610, Aged, Aged, 80 and over, Prostatectomy, 2. Zero hunger, Radiotherapy Planning, Computer-Assisted, Prostatic Neoplasms, Aged, 80 and over [MeSH], Cone-Beam Computed Tomography/methods [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Drinking protocol, Motion [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Original Article, Rectum/radiation effects [MeSH], Male [MeSH], Patient Positioning [MeSH], Adenocarcinoma/radiotherapy [MeSH], Dose Fractionation, Radiation [MeSH], Combined Modality Therapy [MeSH], Adenocarcinoma/diagnostic imaging [MeSH], Endorectal balloon, Prostatic Neoplasms/surgery [MeSH], Adenocarcinoma/blood [MeSH], Radiotherapy, Intensity-Modulated/methods [MeSH], Uncertainty [MeSH], Radiotherapy Planning, Computer-Assisted [MeSH], Cone beam computed tomography, Humans [MeSH], Retrospective Studies [MeSH], Artifacts [MeSH], Fiducial Markers [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Organs at Risk/radiation effects [MeSH], Margin calculation, Prostatectomy [MeSH], Radiotherapy Dosage [MeSH], Adenocarcinoma/surgery [MeSH], Radiotherapy, Image-Guided/methods [MeSH], Radiotherapy Setup Errors [MeSH], Radiotherapy Dosage, Cone-Beam Computed Tomography, Prostate-Specific Antigen, Combined Modality Therapy, 3. Good health, Dose Fractionation, Radiation, Artifacts, Radiotherapy, Image-Guided

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00066-020-01596-x.pdf
https://pubmed.ncbi.nlm.nih.gov/32157345
https://link.springer.com/article/10.1007/s00066-020-01596-x
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305089
https://europepmc.org/article/MED/32157345
https://link.springer.com/content/pdf/10.1007/s00066-020-01596-x.pdf
https://pubmed.ncbi.nlm.nih.gov/32157345/
https://opus4.kobv.de/opus4-fau/files/22520/s00066-020-01596-x.pdf
https://repository.publisso.de/resource/frl:6441852

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities

Autoren: Vassis, Stratos Nöldeke, Beatrice Christiansen, Hans et al.

Quelle: Strahlenther Onkol

Schlagwörter: Male, Organs at Risk, Gastrointestinal Diseases, Aged, 80 and over [MeSH], Localized prostate cancer, Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Seminal Vesicles/radiation effects [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Seminal Vesicles/pathology [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Organ Sparing Treatments/methods [MeSH], Original Article, Rectum/radiation effects [MeSH], Gastrointestinal Diseases/prevention, Male [MeSH], Adenocarcinoma/pathology [MeSH], Gastrointestinal toxicity, Radiation Dose Hypofractionation [MeSH], Adenocarcinoma/radiotherapy [MeSH], Simultan integrierter Boost, Propensity Score [MeSH], Radiation Injuries/etiology [MeSH], Tumor Burden [MeSH], Adenocarcinoma/blood [MeSH], Radiotherapy, Intensity-Modulated/methods [MeSH], Genitourinary toxicity, Follow-Up Studies [MeSH], Urogenitale Toxizität, Cystitis/etiology [MeSH], Humans [MeSH], Moderat hypofraktionierte Strahlentherapie, Moderately hypofractionated radiotherapy, Retrospective Studies [MeSH], Lokal begrenztes Prostatakarzinom, Middle Aged [MeSH], Radiotherapy, Intensity-Modulated/adverse effects [MeSH], Gastrointestinal Diseases/etiology [MeSH], Organs at Risk/radiation effects [MeSH], Time Factors [MeSH], Proctitis/etiology [MeSH], Urination Disorders/etiology [MeSH], Urinary Bladder/radiation effects [MeSH], Gastrointestinale Toxizität, Cystitis/pathology [MeSH], Radiation Injuries/prevention, Simultaneous integrated boost, Proctitis/prevention, Urination Disorders/pathology [MeSH], Adenocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Cystitis, Humans, Proctitis, Propensity Score, Radiation Injuries, Aged, Retrospective Studies, Aged, 80 and over, 2. Zero hunger, Rectum, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, 3. Good health, Radiation Dose Hypofractionation, Radiotherapy, Intensity-Modulated, Organ Sparing Treatments, Follow-Up Studies

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00066-020-01589-w.pdf
https://pubmed.ncbi.nlm.nih.gov/32040691
https://link.springer.com/content/pdf/10.1007/s00066-020-01589-w.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305256
https://link.springer.com/article/10.1007/s00066-020-01589-w
https://europepmc.org/article/MED/32040691
https://repository.publisso.de/resource/frl:6441845

Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.

Autoren: De Bari, B. Fiorentino, A. Greto, D. et al.

Schlagwörter: Aged, 80 and over, Androgen Antagonists/administration & dosage, Androgen Antagonists/therapeutic use, Antineoplastic Agents, Hormonal/administration & dosage, Hormonal/therapeutic use, Biomarkers, Tumor/blood, Brachytherapy, Clinical Trials as Topic, Evidence-Based Medicine, Humans, Immunotherapy, Interdisciplinary Communication, Italy, Male, Middle Aged, Molecular Targeted Therapy/methods, Orchiectomy, Patient Care Team, Practice Patterns, Physicians', Prostate-Specific Antigen/blood, Prostatectomy, Prostatic Neoplasms/blood, Prostatic Neoplasms/diagnosis, Prostatic Neoplasms/drug therapy, Prostatic Neoplasms/radiotherapy, Prostatic Neoplasms/surgery

Relation: Tumori Journal; https://iris.unil.ch/handle/iris/255358; serval:BIB_EEE7315FFC10; 000330925900001

Verfügbarkeit: https://iris.unil.ch/handle/iris/255358
https://doi.org/10.1177/030089161309900601

CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomy.

Autoren: Voutsadakis, I.A. Vlachostergios, P.J. Daliani, D.D. et al.

Schlagwörter: Aged, Chi-Square Distribution, Disease Progression, Disease-Free Survival, Down-Regulation, Greece, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Multivariate Analysis, NF-kappa B/analysis, Neoplasm Grading, Neoplasm Recurrence, Local, Neoplasm Staging, Neprilysin/analysis, Proportional Hazards Models, Prostate-Specific Antigen/blood, Prostatectomy/adverse effects, Prostatic Neoplasms/blood, Prostatic Neoplasms/chemistry, %22">Prostatic Neoplasms/ , Risk Assessment, Risk Factors, Time Factors, Treatment Failure, Up-Regulation

Relation: Urologia Internationalis; https://iris.unil.ch/handle/iris/145817; serval:BIB_9ABC7FA20E3B; 000302134800005

Verfügbarkeit: https://iris.unil.ch/handle/iris/145817
https://doi.org/10.1159/000335299

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.

Autoren: Ioannidou, E. Moschetta, M. Shah, S. et al.

Schlagwörter: Angiogenesis Inhibitors/pharmacology, Angiogenesis Inhibitors/therapeutic use, Animals, Antineoplastic Agents/pharmacology, Antineoplastic Agents/therapeutic use, Drug Resistance, Neoplasm, Humans, Male, Molecular Targeted Therapy, Neovascularization, Pathologic/drug therapy, Prostatic Neoplasms/blood supply, Prostatic Neoplasms/drug therapy, advances, antiangiogenics, castration-resistant prostate cancer, hormone-sensitive prostate cancer, prostate cancer

Dateibeschreibung: application/pdf

Relation: International Journal of Molecular Sciences; https://iris.unil.ch/handle/iris/128639; serval:BIB_3CFEA4E724AA; 000699688500001

Verfügbarkeit: https://iris.unil.ch/handle/iris/128639
https://doi.org/10.3390/ijms22189926